Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 12—December 2015
Dispatch

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea

Wan Beom Park1, Ranawaka A.P.M. Perera1, Pyoeng Gyun Choe, Eric H.Y. Lau, Seong Jin Choi, June Young Chun, Hong Sang Oh, Kyoung-Ho Song, Ji Hwan Bang, Eu Suk Kim, Hong Bin Kim, Sang Won Park, Nam Joong Kim, Leo Lit Man Poon, Ghazi KayaliComments to Author , and Myoung-don OhComments to Author 
Author affiliations: Seoul National University College of Medicine, Seoul, South Korea (W.B. Park, P.G. Choe, S.J. Choi, J.Y. Chun, H.S. Oh, K.-H. Song, J.H. Bang, E.S. Kim, H.B. Kim, S.W. Park, N.J. Kim, M.-d. Oh); The University of Hong Kong, Pokfulam, Hong Kong, China (R.A.P.M. Perera, E.H.Y. Lau, L.L.M. Poon); Hong Kong University–Pasteur Research Pole, Pokfulam (M. Peiris)

Main Article

Figure

Antibody response kinetics in patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection, by days after illness onset, as determined by using a 50% endpoint plaque reduction neutralization test (PRNT50) (A) and an S1 IgG ELISA (B). Key indicates individual patients; Red indicates patients with severe illness requiring mechanical ventilation; blue indicates patients with severe illness requiring only supplemental oxygen therapy; and green indicates patients with mild illness.

Figure. Antibody response kinetics in patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection, by days after illness onset, as determined by using a 50% endpoint plaque reduction neutralization test (PRNT50) (A) and an S1 IgG ELISA (B). Key indicates individual patients; Red indicates patients with severe illness requiring mechanical ventilation; blue indicates patients with severe illness requiring only supplemental oxygen therapy; and green indicates patients with mild illness. For better presentation, the PRNT50 titers have been jittered vertically (random noise added to prevent overplotting) (7) by adding random numbers to the titers within the range of −0.2 to 0.2 at the log scale. OD, optical density.

Main Article

References
  1. Yang  JS, Park  S, Kim  YJ, Kang  HJ, Kim  H, Han  YW, Middle East respiratory syndrome in 3 persons, South Korea, 2015. Emerg Infect Dis. 2015 Nov [cited 2015 Sep 5]. http://wwwnc.cdc.gov/eid/article/21/11/15-1016_article
  2. World Health Organization. Western Pacific Region. Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV in Republic of Korea at a glance; as of 29 July2015 [cited 2015 Sep 7]. http://www.wpro.who.int/outbreaks_emergencies/wpro_coronavirus/en/
  3. Republic of Korea, Ministry of Health. Press release. MERS statistics (as of August 18, 2015) [cited 2015 Sep 7]. http://www.mers.go.kr/mers/html/jsp/Menu_C/list_C4.jsp
  4. Meyer  B, Drosten  C, Müller  MA. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014;194:175–83. DOIPubMedGoogle Scholar
  5. Muth  D, Corman  VM, Meyer  B, Assiri  A, Al-Masri  M, Farah  M, Infectious Middle East respiratory syndrome coronavirus excretion and serotype variability based on live virus isolates from patients in Saudi Arabia. J Clin Microbiol. 2015. Epub 2015 Jul 8.
  6. Drosten  C, Meyer  B, Müller  MA, Corman  VM, Al-Masri  M, Hossain  R, Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014;371:828–35. DOIPubMedGoogle Scholar
  7. Wicklin  R. SAS Institute. Jittering to prevent overplotting in statistical graphics [cited 2015 Sep 10]. http://blogs.sas.com/content/iml/2011/07/05/jittering-to-prevent-overplotting-in-statistical-graphics.html
  8. Zhang  A, Huang  Y, Tian  D, Lau  EH, Wan  Y, Liu  X, Kinetics of serological responses in influenza A(H7N9)–infected patients correlate with clinical outcome in China, 2013. Euro Surveill. 2013;18:20657 .PubMedGoogle Scholar
  9. Ho  MS, Chen  WJ, Chen  HY, Lin  SF, Wang  MC, Di  J, Neutralizing antibody response and SARS severity. Emerg Infect Dis. 2005;11:1730–7. DOIPubMedGoogle Scholar
  10. Hemida  MG, Perera  RA, Al Jassim  RA, Kayali  G, Siu  LY, Wang  P, Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill. 2014;19:20828 .PubMedGoogle Scholar
  11. Cao  WC, Liu  W, Zhang  PH, Zhang  F, Richardus  JH. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med. 2007;357:1162–3. DOIPubMedGoogle Scholar

Main Article

1These authors contributed equally to this article.

Page created: November 17, 2015
Page updated: November 17, 2015
Page reviewed: November 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external